Form 4 for PYXS Pyxis Oncology, Inc.

Accepted 2026-03-25 00:00:00 ET · period of report 2025-04-14 · accession 0000905148-26-001434 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
MT	2026-03-25	2025-04-14+	PYXS	HUMPHREY RACHEL	Dir	S - Sale	$1.02	-15.5K	95.2K	-14%	-$15.9K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2025-04-14	S	D	1,400	$0.97	95,405	D	—	—	(F3) The transaction was executed in multiple trades in prices ranging from $0.97 to $0.98. (F2) Reflects sales of common stock executed in multiple transactions. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected within the ranges set forth in footnotes 3 through 4 of this Form 4.
2	Common	Common Stock	2025-04-21	S	D	13,896	$1.03	81,309	D	—	—	(F2) Reflects sales of common stock executed in multiple transactions. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected within the ranges set forth in footnotes 3 through 4 of this Form 4. (F4) The transaction was executed in multiple trades in prices ranging from $0.97 to $1.09.
3	Common	Common Stock	2025-04-17	S	D	200	$0.97	95,205	D	—	—